BCTX
Briacell Therapeutics Corp. Common Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
BCTX Stock Analysis: Buy, Sell, or Hold?
$3.59
-0.10 (-2.71%)
âŧ
5d:
+12.54%
30d:
-3.23%
90d:
+4.36%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
41/100
Position
FAIR
30-Day Fair Range
$3.27 â $3.88
Position: FAIR
Forward P/E & Valuation
-1.1x
Next 12M consensus est.
Wall Street Target
$150.00
+4078.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.95 / $4.08
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: BCTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When BCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BCTX is currently trading at $3.59, which is considered fair relative to its 30-day fair value range of $3.27 to $3.88.
Technical Outlook: Technically, BCTX is showing sideways momentum. Immediate support is located at $2.95, while resistance sits at $4.08.
Market Sentiment: BCTX scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $150.00 (+4078.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BCTX is showing sideways momentum. Immediate support is located at $2.95, while resistance sits at $4.08.
Market Sentiment: BCTX scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $150.00 (+4078.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.27 -
$3.88
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Trading Range & Key Levels
30-Day Trading Range
$3.27 -
$3.88
Current vs Trading Range
FAIR
Support Level
$2.95
Resistance Level
$4.08
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4078.3% below Wall St target ($150.00)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.06
Wall Street Target
$150.00
(+4078.3%)
Share BCTX Analysis
Share this live BCTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BCTX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Citadel Advisors, led by renowned investor Ken Griffin, holds 900,000 BCTXL warrants for $BCTX.
Key Retail Themes:
Investor confidence
Holding by Citadel Advisors
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:46 AM ET
Data refreshes hourly during market hours. Next update: 5:46 AM
Data refreshes hourly during market hours. Next update: 5:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
GPCR
Structure Therapeutics IâĻ |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BCTX Research Pages
